Active Ingredient(s): Tafluprost
FDA Approved: * February 10, 2012
Pharm Company: * MERCK SHARP DOHME
Category: Vision / Eye Health

Tafluprost (trade names Taflotan by Santen Pharmaceutical and Zioptan by Merck in the US) is a prostaglandin analogue. It is used topically (as eye drops) to control the progression of open-angle glaucoma and in the management of ocular hypertension, alone or in combination with other medication. It reduces intraocular pressure by increasing the outflow of aqueous fluid from the eyes.[1][2] Contents 1 Adverse effects 2 Interactions 3 Pharmacology 3.1 Mechani... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zioptan .0045 mg/.3ml Ophthalmic Solution
NDC: 0006-3931
Merck Sharp & Dohme Corp.
Zioptan .0045 mg/.3ml Ophthalmic Solution/ Drops
NDC: 17478-609
Akorn, Inc.
Zioptan .015 mg/ml Ophthalmic Solution/ Drops
NDC: 82584-609
Thea Pharma Inc.